Posts Tagged ‘ pelvic floor ’

Netherlands Newspaper Investigates Mesh Mess

Dec 29th, 2011 | By
Netherlands Newspaper Investigates Mesh Mess

DECEMBER 29,  2011 ~ The Netherlands will begin a patient registry of synthetic gynecological mesh in early 2012 requiring gynecologists to report the growing number of complications emerging from use of the mesh.  The U.S. has yet to establish post-surgery patient tracking to determine the actual number of adverse events.  Investigative reporter, Ellen de Visser
[continue reading...]



Markets for Newer Vaginal Slings and Pelvic Floor Reconstruction Devices to Show Significant Declines, MarketWatch, Press Release by Millennium Research Group, November 7, 2011

Nov 7th, 2011 | By
Markets for Newer Vaginal Slings and Pelvic Floor Reconstruction Devices to Show Significant Declines, MarketWatch, Press Release by Millennium Research Group, November 7, 2011

According to a report issued today, November 7,  by Millennium Research Group (MRG), the market for pelvic floor reconstruction vaginal slings is predicted to decline significantly. Share this:



Suffering in Silence: Jane Dowdall – Life After Prolapse Bladder Surgery with Synthetic Mesh

Oct 31st, 2011 | By
Suffering in Silence: Jane Dowdall – Life After Prolapse Bladder Surgery with Synthetic Mesh

Jane Dowdall, 55,  is from  Ontario, Canada and tells her own story of bladder prolapse repair and her life today. “In early 2009, I was referred to an Ob-Gyn for a bladder prolapse repair. During my pre-op appointment he explained that he would be using stitches for the repair, but since there was a good
[continue reading...]



We hope you find this a helpful resource. National News Editor, Jane Akre, began MDND with the hope of providing the latest news, information and perspective from the regulatory, industry and patient point of view, something that goes under-reported in much of the coverage of medical devices. The public is just now becoming aware that many devices do not undergo the same scrutiny as prescription drugs and are instead grandfathered in under an FDA loophole that has gone largely unchanged since the 1970s. As a result, patients become the post-market clinical trial subjects, and many suffer devastating and permanent injuries.